Home
Products
Treatments
NK Cell Therapy
TILs Therapy
CAR-T Therapy
Testimonials
TILS
NK Cell Therapy
Myasthenia Gravis（MG）
Acute Lymphoblastic Leukemia(B-ALL)
Systemic Lupus Erythematosus(SLE)
Acute Lymphoblastic Leukemia（T-ALL）
Non Hodgkin Lymphoma（NHL）
Multiple Myeloma（MM）
Diffuse Large B-cell Lymphom
B-lymphocytic Leukemia
Myeloma
News
About us
Contact us
Home
Products
Treatments
NK Cell Therapy
TILs Therapy
CAR-T Therapy
Testimonials
TILS
NK Cell Therapy
Myasthenia Gravis（MG）
Acute Lymphoblastic Leukemia(B-ALL)
Systemic Lupus Erythematosus(SLE)
Acute Lymphoblastic Leukemia（T-ALL）
Non Hodgkin Lymphoma（NHL）
Multiple Myeloma（MM）
Diffuse Large B-cell Lymphom
B-lymphocytic Leukemia
Myeloma
News
About us
Contact us
Home
News
Bioocus Advances the Frontier in Treating Pediatric Acute Lymphoblastic Leukemia
2024-08-19 19:47
Bioocus is at the forefront of developing next-generation CAR-T therapies. The recent publication by Dr. Chunrong Tong and her team at Lu Daopei Hospital highlights critical advancements and challenge...
Pioneering CAR-T Therapy in B-cell Acute Lymphoblastic Leukemia Shows Unprecedented Efficacy
2024-08-14 17:20
A groundbreaking study highlights the remarkable effectiveness of CAR-T cell therapy in treating B-cell Acute Lymphoblastic Leukemia (B-ALL). The research, involving collaboration with BIOOCUS and Lu ...
Innovative CAR-T Cell Therapies Transform Treatment of B Cell Malignancies
2024-08-02 17:22
Researchers from Lu Daopei Hospital and international collaborators explore cutting-edge CAR-T cell therapies, offering hope for patients with B cell malignancies. This study highlights advancements i...
Enhanced Antitumor Efficacy of 4-1BB-Based CD19 CAR-T Cells in Treating B-ALL
2024-08-01 16:21
Recent clinical studies reveal that 4-1BB-based CD19 CAR-T cells demonstrate superior antitumor efficacy compared to CD28-based CAR-T cells in treating relapsed or refractory B cell acute lymphoblasti...
Lu Daopei Hospital's Low-Dose CD19 CAR-T Therapy Shows Promising Results in B-ALL Patients
2024-07-30 15:00
A recent study at Lu Daopei Hospital demonstrated the high efficacy and safety of low-dose CD19 CAR-T cell therapy in treating refractory or relapsed B acute lymphoblastic leukemia (B-ALL) patients. T...
1
2
3
4
5